Provided by Tiger Trade Technology Pte. Ltd.

Cardinal Health

229.51
+1.050.46%
Post-market: 230.000.4900+0.21%19:53 EDT
Volume:1.39M
Turnover:318.21M
Market Cap:53.38B
PE:31.74
High:231.29
Open:228.80
Low:228.16
Close:228.46
52wk High:258.30
52wk Low:145.87
Shares:232.58M
Float Shares:232.58M
Volume Ratio:0.84
T/O Rate:0.60%
Dividend:2.05
Dividend Rate:0.89%
EPS(TTM):7.23
EPS(LYR):7.23
ROE:-171.32%
ROA:3.72%
PB:-18.51
PE(LYR):31.74

Loading ...

Cardinal Health to Report Fiscal 2026 Fourth-quarter, Year-end Results, Host Webcast

Reuters
·
Jul 09

Cardinal Health Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Evercore ISI Adjusts Price Target on Cardinal Health to $265 From $240

MT Newswires Live
·
Jul 07

Is Cardinal Health (CAH) Fully Valued After Its Russell Index Removal?

Simply Wall St.
·
Jul 04

Cardinal Health is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 02

BofA Securities Adjusts Cardinal Health Price Target to $260 From $240

MT Newswires Live
·
Jul 02

Bank of America Securities Reaffirms Their Buy Rating on Cardinal Health (CAH)

TIPRANKS
·
Jul 02

Neurocrine Begins Phase 2 Trial of Crinecerfont in Children Under 4 Years With Classic CAH Genetic Condition

MT Newswires Live
·
Jul 02

Cardinal Health Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

Cardinal Health Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 24

What Neurocrine Biosciences (NBIX)'s New CRENESSITY CAH Data Means For Shareholders

Simply Wall St.
·
Jun 22

Cardinal Health Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 19

Cardinal Health Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Jun 16

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

GlobeNewswire
·
Jun 15

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 13

William O'Neil Initiates Cardinal Health at Buy

MT Newswires Live
·
Jun 12

Barclays Keeps Their Buy Rating on Cardinal Health (CAH)

TIPRANKS
·
Jun 10

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 10

How Investors Are Reacting To Cardinal Health (CAH) Raising Guidance While Expanding Theranostics Amid Recall

Simply Wall St.
·
Jun 08